The infectious pancreatic necrosis market is projected to grow from USD 956.6 million in 2026 to USD 2,203.1 million by 2036, at a CAGR of 8.7%. Vaccines will dominate with a 54.0% market share, while salmonids will lead the species segment with a 72.0% share.